|
Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||
| October 2012 Volume 13 Number 10 | Advertisement | ||||||||||||||||||||||||||||||||||||
| In this issue
|
| |||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
![]() | |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| REVIEWS | Top | ||||||||||||||||||||||||||||||||||||
DNA methylation profiling in the clinic: applications and challenges Holger Heyn & Manel Esteller p679 | doi:10.1038/nrg3270 Epigenetic alterations, notably in DNA hypermethylation, are emerging as consistent biomarkers for disease. Here, with a focus on cancer, the authors discuss the identification of these biomarkers and their use in disease diagnosis, prognosis and response to therapy. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
The telomere syndromes Mary Armanios & Elizabeth H. Blackburn p693 | doi:10.1038/nrg3246 Telomeres have long been implicated in processes of cellular ageing. This Review discusses how a diverse range of human diseases are now known to be caused by mutations that result in defective telomere maintenance and shortened telomeres. It describes the unique inheritance patterns of telomere defects and how telomere biology sheds light into several disease mechanisms. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Analysing and interpreting DNA methylation data Christoph Bock p705 | doi:10.1038/nrg3273 The analysis and interpretation of genome-wide DNA methylation data poses unique bioinformatics challenges. In this article, the tools that are available for processing, visualizing and interpreting these epigenetic data sets are discussed, and the relative advantages of various methods are considered. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans Karen Adelman & John T. Lis p720 | doi:10.1038/nrg3293 Emerging evidence points towards RNA polymerase II promoter-proximal pausing as a widespread regulatory mechanism in higher eukaryotes. Here, the authors discuss the evidence for this from genome-wide studies and present potential functions of this regulatory mechanism. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Genetic and epigenetic stability of human pluripotent stem cells Riikka J. Lund, Elisa Närvä & Riitta Lahesmaa p732 | doi:10.1038/nrg3271 Human pluripotent stem cells hold promise for disease modelling and for cell-based regenerative medicine. This Review summarizes our growing understanding of the genetic and epigenetic abnormalities that can occur in these cells, including their phenotypic consequences and the safety implications for therapies. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| PERSPECTIVES | Top | ||||||||||||||||||||||||||||||||||||
| OPINION Revising the human mutation rate: implications for understanding human evolution Aylwyn Scally & Richard Durbin p745 | doi:10.1038/nrg3295 Recent measurements of the human mutation rate using next-generation sequencing have revealed a value of approximately half of that previously derived from fossil calibration. Here, the authors discuss the implications of this revised mutation rate in relation to our understanding of human evolution. Abstract | Full Text | PDF | Supplementary information | |||||||||||||||||||||||||||||||||||||
| Corrigendum: Improving human forensics through advances in genetics, genomics and molecular biology Manfred Kayser & Peter de Knijff p753 | doi:10.1038/nrg3327 Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| *2011 Journal Citation Report (Thomson Reuters, 2012) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
![]() |











No comments:
Post a Comment